Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Enalapril on Doxorubicin Exposure in Adjuvant Breast Cancer Treatment

NCT00895414 is registered in ClinicalTrials.gov with Masonic Cancer Center, University of Minnesota as lead sponsor.

NCT NCT00895414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00895414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Enalapril on Doxorubicin Exposure in Adjuvant Breast Cancer Treatment
Lead sponsor
Masonic Cancer Center, University of Minnesota
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2009
Completion date
October 31, 2015
Enrollment
19 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer